The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Abstract
Tumor progression is a complex, multistage process by which a normal cell undergoes genetic changes that result in phenotypic alterations and the acquisition of the ability to spread and colonize distant sites in the body. Although many factors regulate malignant tumor growth and spread, interactions between a tumor and its surrounding microenvironment result in the production of important protein products that are crucial to each step of tumor progression. The matrix metalloproteinases (MMPs) are a family of degradative enzymes with clear links to malignancy. These enzymes are associated with tumor cell invasion of the basement membrane and stroma, blood vessel penetration, and metastasis. They have more recently been implicated in primary and metastatic tumor growth and angiogenesis, and they may even have a role in tumor promotion. This review outlines our current understanding of the MMP family, including the association of particular MMPs with malignant phenotypes and the role of MMPs in specific steps of the metastatic cascade. As scientific understanding of the MMPs has advanced, therapeutic strategies that capitalize on blocking the enzymes have rapidly developed. The preclinical and clinical evolution of the synthetic MMP inhibitors (MMPIs) is also examined, with the discussion encompassing important methodologic issues associated with determining clinical efficacy of MMPIs and other novel therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980) · Nature · doi:10.1038/284067a0 · Cited by 1,768
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Self-citationBiology and biochemistry of proteinases in tumor invasion
Mignatti, P., & Rifkin, D. B. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.161 · Cited by 1,244
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., & Chambon, P. (1990) · Nature · doi:10.1038/348699a0 · Cited by 1,131
Molecular architecture of basement membranes
Yurchenco, P. D., & Schittny, J. C. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.6.2180767 · Cited by 944
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Cited by
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
“Thus like the many proteins they modify, the MMPs influence diverse physiologic and pathologic processes, including aspects of embryonic development, tissue morphogenesis, wound repair, inflammatory diseases, and cancer (Nelson et al. 2000, Sternlicht et al. 2001).”
BackgroundReactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Self-citationNishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Self-citationMatrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
Self-citationMolecular mechanisms of blood vessel growth
Conway, E. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00281-9 · Cited by 1,030
Reactive oxygen species in tumor progression
Storz, P. (2005) · Frontiers in Bioscience · doi:10.2741/1667 · Cited by 957
Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918
Self-citationProgress in corneal wound healing
Ljubimov, A. V., & Saghizadeh, M. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.002 · Cited by 872
Matrix metalloproteinases in neuroinflammation
Rosenberg, G. A. (2002) · Glia · doi:10.1002/glia.10108 · Cited by 868
Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype
Kumar, B., Koul, S., Khandrika, L., Meacham, R. B., & Koul, H. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5259 · Cited by 736
Matrix-Degrading Metalloproteinases in Photoaging
Quan, T., Qin, Z., Xia, W., Shao, Y., Voorhees, J. J., & Fisher, G. J. (2009) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/jidsymp.2009.8 · Cited by 740
In vivo molecular target assessment of matrix metalloproteinase inhibition
Bremer, C., Tung, C.-H., & Weissleder, R. (2001) · Nature Medicine · doi:10.1038/89126 · Cited by 726
Matrix Metalloproteinases: Regulation and Dysregulation in the Failing Heart
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 726
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Inflammation after Intracerebral Hemorrhage
Wang, J., & Doré, S. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600403 · Cited by 651
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Vihinen, P., & Kähäri, V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10329 · Cited by 637
Zimna, A., & Kurpisz, M. (2015) · BioMed Research International · doi:10.1155/2015/549412 · Cited by 604
“Subsequently, matrix metalloproteinases (MMPs) enhance angiogenesis through the degradation of matrix components [10].”
BackgroundMatrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112260 · Cited by 556
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
Zucker, S., Cao, J., & Chen, W.-T. (2000) · Oncogene · doi:10.1038/sj.onc.1204097 · Cited by 550
Protective strategies against ischemic injury of the liver
SELZNER, N. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01048-5 · Cited by 546
de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
Moradi Kashkooli, F., Soltani, M., & Souri, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.012 · Cited by 514
Role of matrix metalloproteinases (MMPs) in colorectal cancer
Zucker, S., & Vacirca, J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025867130437 · Cited by 506
Weng, C.-J., & Yen, G.-C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.03.001 · Cited by 485
Chung, T., Moon, S., Chang, Y., Ko, J., Lee, Y., Cho, G., Kim, S., Kim, J., & Kim, C. (2004) · The FASEB Journal · doi:10.1096/fj.04-2126com · Cited by 456
Activity-based probes for the proteomic profiling of metalloproteases
Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M., & Cravatt, B. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402784101 · Cited by 456
Ii, M., Yamamoto, H., Adachi, Y., Maruyama, Y., & Shinomura, Y. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100103 · Cited by 443
Mitochondrial redox control of matrix metalloproteinases
Nelson, K. K., & Melendez, J. A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.008 · Cited by 441
JNK‐ and Fos‐regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila
Uhlirova, M., & Bohmann, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601401 · Cited by 395
New insights into the role of extracellular matrix during tumor onset and progression
Pupa, S. M., Ménard, S., Forti, S., & Tagliabue, E. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10142 · Cited by 419
Molecular Link Mechanisms between Inflammation and Cancer
B. Vendramini-Costa, D., & E. Carvalho, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802083707 · Cited by 417
Agnihotri, R., Crawford, H. C., Haro, H., Matrisian, L. M., Havrda, M. C., & Liaw, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103608200 · Cited by 414
Self-citationMatrix Metalloproteinase-2 Contributes to Cancer Cell Migration on Collagen
Xu, X., Wang, Y., Chen, Z., Sternlicht, M. D., Hidalgo, M., & Steffensen, B. (2005) · Cancer Research · doi:10.1158/0008-5472.130.65.1 · Cited by 413
Multiple roles for MMPs and TIMPs in cerebral ischemia
Cunningham, L. A., Wetzel, M., & Rosenberg, G. A. (2005) · Glia · doi:10.1002/glia.20169 · Cited by 411
Proteases in invasion: matrix metalloproteinases
Stetler-Stevenson, W. G., & Yu, A. E. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0365 · Cited by 411
Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy
Gately, S., & Li, W. W. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.040 · Cited by 398
Fata, J. E., Werb, Z., & Bissell, M. J. (2003) · Breast Cancer Research · doi:10.1186/bcr634 · Cited by 383
Cauwe, B., Van den Steen, P. E., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 381
Stimuli‐Responsive Materials for Controlled Release of Theranostic Agents
Wang, Y., Shim, M. S., Levinson, N. S., Sung, H., & Xia, Y. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201400279 · Cited by 378
On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
Piccard, H., Muschel, R. J., & Opdenakker, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.06.004 · Cited by 373
Brennan, M., Bhatti, H., Nerusu, K. C., Bhagavathula, N., Kang, S., Fisher, G. J., Varani, J., & Voorhees, J. J. (2007) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2003)0780043mmitmc2.0.co2 · Cited by 358
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia
Rosenberg, G. A., & Yang, Y. (2007) · Neurosurgical Focus · doi:10.3171/foc.2007.22.5.5 · Cited by 357
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia
Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.001 · Cited by 350
Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer
Kerkelä, E., & Saarialho‐Kere, U. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.120201.x · Cited by 345
Tang, Y., Nakada, M. T., Kesavan, P., McCabe, F., Millar, H., Rafferty, P., Bugelski, P., & Yan, L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3605 · Cited by 337
Jacobsen, J. A., Major Jourden, J. L., Miller, M. T., & Cohen, S. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.08.006 · Cited by 313
Beneficial Effects of Marine Algal Compounds in Cosmeceuticals
Thomas, N., & Kim, S.-K. (2013) · Marine Drugs · doi:10.3390/md11010146 · Cited by 302
Mouse models for human lung cancer
Meuwissen, R., & Berns, A. (2005) · Genes & Development · doi:10.1101/gad.1284505 · Cited by 302
Sieczkiewicz, G. J., Hussain, M., & Kohn, E. C. (2002) · Ovarian Cancer · doi:10.1007/978-1-4757-3587-1_17 · Cited by 295
Inhibition of tumor angiogenesis by cannabinoids
Blázquez, C., Casanova, M. L., Planas, A., Gómez del Pulgar, T., Villanueva, C., Fernández‐Aceñero, M. J., Aragonés, J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0795fje · Cited by 292
Chung, T., Lee, Y., & Kim, C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1429fje · Cited by 288
Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy
Kang, T., Li, F., Baik, S., Shao, W., Ling, D., & Hyeon, T. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.013 · Cited by 280
The disturbed blood–brain barrier in human glioblastoma
Wolburg, H., Noell, S., Fallier-Becker, P., Mack, A. F., & Wolburg-Buchholz, K. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.02.003 · Cited by 277
Potential pharmacological applications of polyphenolic derivatives from marine brown algae
Thomas, N. V., & Kim, S.-K. (2011) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2011.09.004 · Cited by 269
Pfefferkorn, T., & Rosenberg, G. A. (2003) · Stroke · doi:10.1161/01.str.0000083051.93319.28 · Cited by 272
Matrix metalloproteinases: roles in cancer and metastasis
Fingleton, B. (2006) · Frontiers in Bioscience · doi:10.2741/1811 · Cited by 271
Self-citationStudy of matrix metalloproteinases and their inhibitors in breast cancer
Vizoso, F. J., González, L. O., Corte, M. D., Rodríguez, J. C., Vázquez, J., Lamelas, M. L., Junquera, S., Merino, A. M., & García-Muñiz, J. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603666 · Cited by 271
The mechanisms by which polyamines accelerate tumor spread
Soda, K. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-95 · Cited by 270
Sparano, J. A., Bernardo, P., Stephenson, P., Gradishar, W. J., Ingle, J. N., Zucker, S., & Davidson, N. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.054 · Cited by 269
The promise of cancer vaccines
Gilboa, E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1359 · Cited by 267
Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis
Foda, H. D., & Zucker, S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01752-4 · Cited by 262
Jiang, H., & Li, H. (2021) · BMC Cancer · doi:10.1186/s12885-021-07860-2 · Cited by 261
Roles of circRNAs in the tumour microenvironment
Zhang, Q., Wang, W., Zhou, Q., Chen, C., Yuan, W., Liu, J., Li, X., & Sun, Z. (2020) · Molecular Cancer · doi:10.1186/s12943-019-1125-9 · Cited by 260
The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy
Wang, X., Song, X., Zhuo, W., Fu, Y., Shi, H., Liang, Y., Tong, M., Chang, G., & Luo, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908151106 · Cited by 259
Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A., Bassilopoulos, P., Trangas, T., & Talieri, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1810 · Cited by 258
Tang, Y., Kesavan, P., Nakada, M. T., & Yan, L. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.73.2.2 · Cited by 256
Castellana, D., Zobairi, F., Martinez, M. C., Panaro, M. A., Mitolo, V., Freyssinet, J.-M., & Kunzelmann, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1946 · Cited by 255
Optical Imaging of Matrix Metalloproteinase–2 Activity in Tumors: Feasibility Study in a Mouse Model
Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., & Tung, C.-H. (2001) · Radiology · doi:10.1148/radiol.2212010368 · Cited by 255
Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation
Muñoz-Nájar, U. M., Neurath, K. M., Vumbaca, F., & Claffey, K. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209273 · Cited by 209
“They are also involved in the regulation of cell proliferation, release of growth factors and angiogenesis (Nelson et al., 2000; Stetler-Stevenson and Yu, 2001).”
BackgroundMatrix metalloproteinase collagenolysis in health and disease
Amar, S., Smith, L., & Fields, G. B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.015 · Cited by 194
McCarty, S. M., Cochrane, C. A., Clegg, P. D., & Percival, S. L. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00763.x · Cited by 193
The Design of Inhibitors for Medicinally Relevant Metalloproteins
Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600204 · Cited by 132
miR‐338‐3p suppresses invasion of liver cancer cell by targeting smoothened
Huang, X., Chen, J., Wang, Q., Chen, X., Wen, L., Chen, L., Bi, J., Zhang, L., Su, Q., & Zeng, W. (2011) · The Journal of Pathology · doi:10.1002/path.2877 · Cited by 118
Sosne, G., Christopherson, P. L., Barrett, R. P., & Fridman, R. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1368 · Cited by 108
Llano, E., Adam, G., Pendás, A. M., Quesada, V., Sánchez, L. M., Santamarı́a, I., Noselli, S., & López-Otı́n, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200121200 · Cited by 100
Baillat, D., Bègue, A., Stéhelin, D., & Aumercier, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200088200 · Cited by 84
Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice
Kang, L., Mayes, W. H., James, F. D., Bracy, D. P., & Wasserman, D. H. (2014) · Diabetologia · doi:10.1007/s00125-013-3128-1 · Cited by 48
Dilshara, M. G., Kang, C.-H., Choi, Y. H., & Kim, G.-Y. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.10.003 · Cited by 47
“in promoting the progression of carcinogenesis (22, 23).”
BackgroundTakeda, T., Tsubaki, M., Sakamoto, K., Ichimura, E., Enomoto, A., Suzuki, Y., Itoh, T., Imano, M., Tanabe, G., Muraoka, O., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.07.005 · Cited by 42
Host Response to Naturally Derived Biomaterials
Lopresti, S. T., & Brown, B. N. (2015) · Host Response to Biomaterials · doi:10.1016/b978-0-12-800196-7.00004-9 · Cited by 24
Differential expression of degradome components in cutaneous squamous cell carcinomas
Prasad, N. B., Fischer, A. C., Chuang, A. Y., Wright, J. M., Yang, T., Tsai, H.-L., Westra, W. H., Liegeois, N. J., Hess, A. D., & Tufaro, A. P. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.217 · Cited by 17
Metadata
- Authors
- Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-03-01
- Volume
- 18
- Issue
- 5
- Pages
- 1135-1135
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1886431664
- Cited by
- 1,554
- References
- 79
- FWCI
- 36.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.